HEPA · Hepion Pharmaceuticals, Inc. · Exempt Offerings
$0.14
-0.18 (-57.55%)
At close · May 13
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to our recurring and expected continuing losses from operations, we have concluded there is substantial doubt in our ability to continue as a going concern within one year of the issuance of these condensed consolidated financial statements without additional capital becoming available to us.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.77M
Shares
90.22M
Volume · May 13
1.91M
Avg daily vol (40 sessions)
7.18M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-08-05 | New | Biotechnology | $3,055,000 | $3,055,000 | 06b |
| 2026-04-22 | New | Biotechnology | $700,000 | $700,000 | 06b |
| 2024-07-24 | New | Pharmaceuticals | $2,900,000 | $2,900,000 | 06b |
| 2023-10-03 | New | Pharmaceuticals | $5,000,004 | $5,000,004 | 06b |
| 2022-11-15 | New | Biotechnology | $20,000,000 | $20,000,000 | 06b |
Showing 1–5 of 5 filings